JMIR Aging invites submissions on next-generation ambient intelligence: “invisible” monitoring and AI adoption for aging-in-place
Business Announcement
Updates every hour. Last Updated: 28-Oct-2026 22:17 ET (29-Oct-2026 02:17 GMT/UTC)
Insilico Medicine has announced the program for ARDD 2026, the 13th Aging Research & Drug Discovery Meeting, taking place October 1–3 at the David Rubenstein Treehouse at Harvard University in Boston.
The three-day program will convene global leaders from pharmaceutical and biotechnology companies, academia, clinical medicine, investment, artificial intelligence, scientific publishing and policy. Sessions will span aging biology, therapeutic discovery, clinical development, regulatory strategy, partnering and investment, reflecting the growing maturity of longevity biotechnology.
Insilico Medicine has announced the program for ARDD 2026, the 13th Aging Research & Drug Discovery Meeting, taking place October 1–3 at the David Rubenstein Treehouse at Harvard University in Boston.
The three-day program will convene global leaders from pharmaceutical and biotechnology companies, academia, clinical medicine, investment, artificial intelligence, scientific publishing and policy. Sessions will span aging biology, therapeutic discovery, clinical development, regulatory strategy, partnering and investment, reflecting the growing maturity of longevity biotechnology.
Older adults who typically had longer intervals between meals accumulated chronic diseases more rapidly over time than those with shorter intervals, according to a study from Karolinska Institutet published in the Journal of Internal Medicine. The association was most pronounced among people aged 78 years and older.
Recently, researchers from the Department of Neurosurgery and Neurosurgery Research Laboratory at West China Hospital of Sichuan University published a comprehensive review article in the Chinese Medical Journal focusing on the regulation and targeted therapy of the tumor immune and non-immune microenvironment. The review provides a complex scope of a new hotspot in glioma research and treatment: the glioma microenvironment and its targeted therapies.Recently, researchers from the Department of Neurosurgery and Neurosurgery Research Laboratory at West China Hospital of Sichuan University published a comprehensive review article in the Chinese Medical Journal focusing on the regulation and targeted therapy of the tumor immune and non-immune microenvironment. The review provides a complex scope of a new hotspot in glioma research and treatment: the glioma microenvironment and its targeted therapies.